Tenofovir disoproxil fumarate for patients with chronic hepatitis B who have previously failed lamivudine and adefovir

被引：0
|
作者：
Patterson, S. J. [1 ]
George, J. [2 ]
Strasser, S. I. [3 ]
Lee, A. U. [4 ]
Sievert, W. [5 ]
Nicoll, A. J. [6 ]
Desmonad, P. V. [7 ]
Roberts, S. K. [8 ]
Locarnini, S. [9 ]
Bowden, S. [9 ]
Angus, P. W. [1 ]
机构：
[1] Austin Hlth, Melbourne, Vic, Australia
[2] Westmead Hosp, Westmead, NSW, Australia
[3] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[4] Concord Repatriat Gen Hosp, Sydney, NSW, Australia
[5] Monash Med Ctr, Clayton, Vic, Australia
[6] Royal Melbourne Hosp, Melbourne, Vic, Australia
[7] St Vincents Hosp, Melbourne, Vic, Australia
[8] Alfred Hosp, Melbourne, Vic, Australia
[9] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [1] TENOFOVIR DISOPROXIL FUMARATE FOR PATIENTS WITH CHRONIC HEPATITIS B WHO HAVE PREVIOUSLY FAILED LAMIVUDINE AND ADEFOVIR: EFFECTS OF BASELINE SEQUENCE MUTATIONS ON VIROLOGICAL RESPONSE
    Patterson, Scott
    George, Jacob
    Strasser, Simone I.
    Lee, Alice U.
    Sievert, William
    Nicoll, Amanda J.
    Desmond, Paul V.
    Roberts, Stuart K.
    Locarnini, Stephen
    Bowden, Scott
    Angus, Peter W.
    [J]. HEPATOLOGY, 2009, 50 (04) : 534A - 535A
  • [2] A PROSPECTIVE STUDY OF TENOFOVIR DISOPROXIL FUMARATE FOR PATIENTS WITH CHRONIC HEPATITIS B WHO HAVE PREVIOUSLY FAILED LAMIVUDINE AND AND HAVE SIGNIFICANT VIRAL REPLICATION DESPITE AT LEAST 24 WEEKS OF ADEFOVIR DIPIVOXIL THERAPY
    Patterson, Scott
    George, Jacob
    Strasser, Simone I.
    Lee, Alice U.
    Sievert, William
    Nicoll, Amanda J.
    Desmond, Paul V.
    Roberts, Stuart K.
    Angus, Peter W.
    [J]. HEPATOLOGY, 2008, 48 (04) : 748A - 748A
  • [3] A prospective study of tenofovir disoproxil fumarate for patients with chronic hepatitis B who have previously failed lamivudine and have significant viral replication despite at least 24 weeks of adefovir dipivoxil therapy
    Patterson, S. J.
    George, J.
    Strasser, S. I.
    Lee, A. U.
    Sievert, W.
    Nicoll, A. J.
    Desmonad, P. V.
    Roberts, S. K.
    Angus, P. W.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A257 - A257
  • [4] Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients
    Dan-Hong Yang
    Yuan-Jun Xie
    Nian-Feng Zhao
    Hong-Ying Pan
    Ming-Wei Li
    Hai-Jun Huang
    [J]. World Journal of Gastroenterology, 2015, (09) : 2746 - 2753
  • [5] Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients
    Yang, Dan-Hong
    Xie, Yuan-Jun
    Zhao, Nian-Feng
    Pan, Hong-Ying
    Li, Ming-Wei
    Huang, Hai-Jun
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (09) : 2746 - 2753
  • [6] Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
    Marcellin, Patrick
    Heathcote, E. Jenny
    Buti, Maria
    Gane, Ed
    de Man, Robert A.
    Krastev, Zahary
    Germanidis, George
    Lee, Sam S.
    Flisiak, Robert
    Kaita, Kelly
    Manns, Michael
    Kotzev, Iskren
    Tchernev, Konstantin
    Buggisch, Peter
    Weilert, Frank
    Kurdas, Oya Ovung
    Shiffman, Mitchell L.
    Trinh, Huy
    Washington, Mary Kay
    Sorbel, Jeff
    Anderson, Jane
    Snow-Lampart, Andrea
    Mondou, Elsa
    Quinn, Joe
    Rousseau, Franck
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (23): : 2442 - 2455
  • [7] Switching to Tenofovir Disoproxil Fumarate and Lamivudine Combination Therapy in Patients With Chronic Hepatitis B and Poor Response to Adefovir and Lamivudine Combination Therapy
    Mita, Eiji
    Ishida, Hisashi
    Imai, Yasuharu
    Kato, Michio
    Ohta, Hajime
    Shimada, Masaaki
    Nakamuta, Makoto
    Yatsuhashi, Hiroshi
    Masaki, Naohiko
    Suzuki, Yoshiyuki
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S883 - S884
  • [8] Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B
    Fung, Scott
    Kwan, Peter
    Fabri, Milotka
    Horban, Andrzej
    Pelemis, Mijomir
    Hann, Hie-Won
    Gurel, Selim
    Caruntu, Florin A.
    Flaherty, John F.
    Massetto, Benedetta
    Dinh, Phillip
    Corsa, Amoreena
    Subramanian, G. Mani
    McHutchison, John G.
    Husa, Petr
    Gane, Edward
    [J]. GASTROENTEROLOGY, 2014, 146 (04) : 980 - U521
  • [9] Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
    Patterson, S. J.
    George, J.
    Strasser, S. I.
    Lee, A. U.
    Sievert, W.
    Nicoll, A. J.
    Desmond, P. V.
    Roberts, S. K.
    Locarnini, S.
    Bowden, S.
    Angus, P. W.
    [J]. GUT, 2011, 60 (02) : 247 - 254
  • [10] Tenofovir Disoproxil Fumarate In Chronic Hepatitis B
    Perry, Caroline M.
    Simpson, Dene
    [J]. DRUGS, 2009, 69 (16) : 2245 - 2256
12345